Vanguard Group’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $928K | Sell |
1,567,868
-3,643,955
| -70% | -$2.16M | ﹤0.01% | 3763 |
|
|
2025
Q1 | $4.57M | Sell |
5,211,823
-63,882
| -1% | -$56K | ﹤0.01% | 3213 |
|
|
2024
Q4 | $8.92M | Buy |
5,275,705
+60,350
| +1% | +$102K | ﹤0.01% | 3014 |
|
|
2024
Q3 | $10M | Buy |
5,215,355
+1,240,071
| +31% | +$2.38M | ﹤0.01% | 2960 |
|
|
2024
Q2 | $9.78M | Buy |
3,975,284
+2,162,205
| +119% | +$5.32M | ﹤0.01% | 2942 |
|
|
2024
Q1 | $2.97M | Sell |
1,813,079
-1,085,965
| -37% | -$1.78M | ﹤0.01% | 3468 |
|
|
2023
Q4 | $5.16M | Sell |
2,899,044
-392,815
| -12% | -$699K | ﹤0.01% | 3274 |
|
|
2023
Q3 | $15.1M | Buy |
3,291,859
+229,078
| +7% | +$1.05M | ﹤0.01% | 2672 |
|
|
2023
Q2 | $34.3M | Sell |
3,062,781
-1,094,397
| -26% | -$12.2M | ﹤0.01% | 2358 |
|
|
2023
Q1 | $47.1M | Buy |
4,157,178
+3,974,528
| +2,176% | +$45M | ﹤0.01% | 2206 |
|
|
2022
Q4 | $1.25M | Buy |
182,650
+30,550
| +20% | +$210K | ﹤0.01% | 3833 |
|
|
2022
Q3 | $1.37M | Buy |
+152,100
| New | +$1.37M | ﹤0.01% | 3892 |
|